Section 1: Purpose
To abolish the Food and Drug Administration (FDA) as a federal regulatory body, promote free-market solutions in pharmaceutical and food safety, and restore decision-making rights to individuals and communities. This act reflects the belief that individuals, guided by personal research and professional advice, are best suited to make decisions regarding their own health.
Section 2: Findings
-
Bureaucratic Inefficiency and Delays: The FDA’s centralized approval process is slow, costly, and has historically delayed life-saving drugs and medical devices. This bureaucracy often deprives Americans of timely access to treatments readily available in other countries.
-
Monopoly on Information: By monopolizing regulatory authority, the FDA restricts the dissemination of information about new drugs and treatments, stifling medical innovation and preventing informed consumer choice.
-
Market-Based Alternatives: Independent certification bodies, private researchers, and patient advocacy groups already play a crucial role in evaluating drugs and food safety. Allowing multiple independent agencies to verify safety and efficacy could improve transparency and accountability.
-
State and Local Autonomy: Health and safety regulations are more effective when tailored to specific community needs. Decentralizing oversight to states, localities, and private organizations will enable tailored, faster, and more flexible safety standards.
Section 3: Abolishment of the FDA
3.1 Effective 90 days after the enactment of this Act, the Food and Drug Administration (FDA) will be dissolved as a federal entity.
3.2 All regulatory authority formerly held by the FDA will be returned to states, municipalities, and private entities, allowing them to establish local or voluntary health and safety standards.
Section 4: Encouragement of Market-Based Certification and Accountability
4.1 The Department of Commerce will facilitate a transition by creating a database listing independent certifying organizations for drugs and food products, providing consumers with access to information on alternative verification sources.
4.2 Companies may voluntarily certify their products through independent agencies that adhere to the following baseline transparency and quality standards, ensuring consumers can trust the certifications provided:
Comprehensive Disclosure: Certifying agencies must publicly disclose all testing methods, study data, and any conflicts of interest. This includes reporting any financial ties to the companies whose products they review.
Independent Testing: Agencies must conduct or commission independent third-party testing, not reliant on the company’s own data. Testing protocols and results must be published online for public scrutiny.
Clear Labeling: Certification labels must include a standard symbol, accompanied by an online link or QR code directing consumers to detailed information about testing methods, safety findings, and any known risks.
Audits and Compliance Checks: To maintain transparency, certifying agencies must undergo annual audits by an independent accreditation body, which will review their compliance with established quality and safety standards.
Consumer Complaint and Review Process: Agencies must maintain a publicly accessible system for tracking consumer complaints and product recalls. Each agency must also conduct a review of certifications if new evidence raises safety concerns.